-
1
-
-
59249101715
-
The global burden of urinary bladder cancer
-
Parkin DM: The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl. 2008; 218: 12-20.
-
(2008)
Scand J Urol Nephrol Suppl
, vol.218
, pp. 12-20
-
-
Parkin, D.M.1
-
2
-
-
30044441045
-
Bladder cancer: epidemiology, staging and grading, and diagnosis
-
Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al.: Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005; 66: 4-34.
-
(2005)
Urology
, vol.66
, pp. 4-34
-
-
Kirkali, Z.1
Chan, T.2
Manoharan, M.3
Algaba, F.4
Busch, C.5
Cheng, L.6
-
3
-
-
34547608288
-
Natural history, recurrence, and progression in superficial bladder cancer
-
Sylvester RJ: Natural history, recurrence, and progression in superficial bladder cancer. Scientific World Journal. 2006; 6: 2617-25.
-
(2006)
Scientific World Journal
, vol.6
, pp. 2617-2625
-
-
Sylvester, R.J.1
-
4
-
-
0030002747
-
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer
-
discussion 1940-1
-
Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MK, et al.: A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol. 1996; 156: 1934-40, discussion 1940-1.
-
(1996)
J Urol
, vol.156
, pp. 1934-1940
-
-
Pawinski, A.1
Sylvester, R.2
Kurth, K.H.3
Bouffioux, C.4
van der Meijden, A.5
Parmar, M.K.6
-
5
-
-
0024306979
-
History of BCG and its substrains
-
Crispen R: History of BCG and its substrains. Prog Clin Biol Res. 1989; 310: 35-50.
-
(1989)
Prog Clin Biol Res
, vol.310
, pp. 35-50
-
-
Crispen, R.1
-
6
-
-
0014664421
-
Active immunotherapy for acute lymphoblastic leukaemia
-
Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, et al.: Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969; 1: 697-9.
-
(1969)
Lancet
, vol.1
, pp. 697-699
-
-
Mathé, G.1
Amiel, J.L.2
Schwarzenberg, L.3
Schneider, M.4
Cattan, A.5
Schlumberger, J.R.6
-
7
-
-
0014825236
-
Immunological factors which influence response to immunotherapy in malignant melanoma
-
discussion 163-4
-
Morton D, Eilber FR, Malmgren RA, Wood WC: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery. 1970; 68: 158-63; discussion 163-4.
-
(1970)
Surgery
, vol.68
, pp. 158-163
-
-
Morton, D.1
Eilber, F.R.2
Malmgren, R.A.3
Wood, W.C.4
-
8
-
-
0015374035
-
Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis
-
Zbar B, Bernstein ID, Bartlett GL, Hanna MG Jr, Rapp HJ: Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J Natl Cancer Inst. 1972; 49: 119-30.
-
(1972)
J Natl Cancer Inst
, vol.49
, pp. 119-130
-
-
Zbar, B.1
Bernstein, I.D.2
Bartlett, G.L.3
Hanna M.G., Jr.4
Rapp, H.J.5
-
9
-
-
0013878104
-
Extracutaneous delayed hypersensitivity, particularly in the guinea-pig bladder
-
Coe JE, Feldman JD: Extracutaneous delayed hypersensitivity, particularly in the guinea-pig bladder. Immunology. 1966; 10: 127-36.
-
(1966)
Immunology
, vol.10
, pp. 127-136
-
-
Coe, J.E.1
Feldman, J.D.2
-
10
-
-
0017130525
-
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors
-
Morales A, Eidinger D, Bruce AW: Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976; 116: 180-3.
-
(1976)
J Urol
, vol.116
, pp. 180-183
-
-
Morales, A.1
Eidinger, D.2
Bruce, A.W.3
-
11
-
-
0021843932
-
Bacillus Calmette-Guerin immunotherapy for bladder cancer
-
Lamm DL: Bacillus Calmette-Guerin immunotherapy for bladder cancer. J Urol. 1985; 134: 40-7.
-
(1985)
J Urol
, vol.134
, pp. 40-47
-
-
Lamm, D.L.1
-
12
-
-
0023001309
-
A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study
-
Mori K, Lamm DL, Crawford ED: A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study. Urol Int. 1986; 41: 254-9.
-
(1986)
Urol Int
, vol.41
, pp. 254-259
-
-
Mori, K.1
Lamm, D.L.2
Crawford, E.D.3
-
13
-
-
0020684282
-
Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder
-
Herr HW, Pinsky CM, Whitmore WF Jr, Oettgen HF, Melamed MR: Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder. Cancer. 1983; 51: 1323-6.
-
(1983)
Cancer
, vol.51
, pp. 1323-1326
-
-
Herr, H.W.1
Pinsky, C.M.2
Whitmore W.F., Jr.3
Oettgen, H.F.4
Melamed, M.R.5
-
14
-
-
0022223561
-
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors
-
Herr HW, Pinsky CM, Whitmore WF Jr, Sogani PG, Oettgen HF, Melamed MR: Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors. Urology. 1985; 25: 119-23.
-
(1985)
Urology
, vol.25
, pp. 119-123
-
-
Herr, H.W.1
Pinsky, C.M.2
Whitmore W.F., Jr.3
Sogani, P.G.4
Oettgen, H.F.5
Melamed, M.R.6
-
15
-
-
0036765909
-
Treatment of patients with superficial bladder cancer stratified by risk groups treated with lyophilized Moreau-Rio de Janeiro BCG strain
-
discussion 435-6
-
Fonseca FP, Bachega W Jr, Zequi SC, Sarkis AS, Guimaraes G, Priante AV, et al.: Treatment of patients with superficial bladder cancer stratified by risk groups treated with lyophilized Moreau-Rio de Janeiro BCG strain. Int Braz J Urol. 2002; 28: 426-35; discussion 435-6.
-
(2002)
Int Braz J Urol
, vol.28
, pp. 426-435
-
-
Fonseca, F.P.1
Bachega W., Jr.2
Zequi, S.C.3
Sarkis, A.S.4
Guimaraes, G.5
Priante, A.V.6
-
16
-
-
44649146617
-
Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study
-
Yoneyama T, Ohyama C, Imai A, Ishimura H, Hagisawa S, Iwabuchi I, et al.: Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study. Urology. 2008; 71: 1161-5.
-
(2008)
Urology
, vol.71
, pp. 1161-1165
-
-
Yoneyama, T.1
Ohyama, C.2
Imai, A.3
Ishimura, H.4
Hagisawa, S.5
Iwabuchi, I.6
-
17
-
-
0027419141
-
Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule
-
Melekos MD, Chionis H, Pantazakos A, Fokaefs E, Paranychianakis G, Dauaher H: Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule. J Urol. 1993; 149: 744-8.
-
(1993)
J Urol
, vol.149
, pp. 744-748
-
-
Melekos, M.D.1
Chionis, H.2
Pantazakos, A.3
Fokaefs, E.4
Paranychianakis, G.5
Dauaher, H.6
-
18
-
-
9444281414
-
A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics
-
Krege S, Giani G, Meyer R, Otto T, Rübben H: A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics. J Urol. 1996; 156: 962-6.
-
(1996)
J Urol
, vol.156
, pp. 962-966
-
-
Krege, S.1
Giani, G.2
Meyer, R.3
Otto, T.4
Rübben, H.5
-
19
-
-
34248595861
-
Randomized prospective study comparing long-term intravesical instillation of BCG after transurethral resection and transurethral resection alone in patients with superficial bladder cancer
-
Iantorno R, Nicolai M, Mastroprimiano G, Ballone E, Passamonti M, Cipollone G, et al.: Randomized prospective study comparing long-term intravesical instillation of BCG after transurethral resection and transurethral resection alone in patients with superficial bladder cancer. J Urol. 1999; 161(Suppl): 284.
-
(1999)
J Urol
, vol.161
, Issue.SUPPL
, pp. 284
-
-
Iantorno, R.1
Nicolai, M.2
Mastroprimiano, G.3
Ballone, E.4
Passamonti, M.5
Cipollone, G.6
-
20
-
-
0026725003
-
Long-term results of intravesical therapy for superficial bladder cancer
-
Lamm DL: Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am. 1992; 19: 573-80.
-
(1992)
Urol Clin North Am
, vol.19
, pp. 573-580
-
-
Lamm, D.L.1
-
21
-
-
0345633575
-
Multivariate analysis of the prognostic factors of primary superficial bladder cancer
-
Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J: Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol. 2000; 163: 73-8.
-
(2000)
J Urol
, vol.163
, pp. 73-78
-
-
Millán-Rodríguez, F.1
Chéchile-Toniolo, G.2
Salvador-Bayarri, J.3
Palou, J.4
Vicente-Rodríguez, J.5
-
22
-
-
0034565464
-
Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer
-
Shelley MD, Court JB, Kynaston H, Wilt TJ, Fish RG, Mason M: Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer. Cochrane Database Syst Rev. 2000: CD001986.
-
(2000)
Cochrane Database Syst Rev
-
-
Shelley, M.D.1
Court, J.B.2
Kynaston, H.3
Wilt, T.J.4
Fish, R.G.5
Mason, M.6
-
23
-
-
0027172391
-
Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study
-
Witjes JA, Fransen MP, van der Meijden AP, Doesburg WH, Debruyne FM: Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study. Urol Int. 1993; 51: 67-72.
-
(1993)
Urol Int
, vol.51
, pp. 67-72
-
-
Witjes, J.A.1
Fransen, M.P.2
van der Meijden, A.P.3
Doesburg, W.H.4
Debruyne, F.M.5
-
24
-
-
0036837453
-
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials
-
Sylvester RJ, van der Meijden AP, Lamm DL: Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002; 168: 1964-70.
-
(2002)
J Urol
, vol.168
, pp. 1964-1970
-
-
Sylvester, R.J.1
van der Meijden, A.P.2
Lamm, D.L.3
-
25
-
-
33744513525
-
Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials
-
Han RF, Pan JG: Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology. 2006; 67: 1216-23.
-
(2006)
Urology
, vol.67
, pp. 1216-1223
-
-
Han, R.F.1
Pan, J.G.2
-
26
-
-
33745513016
-
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer
-
National BCG-Interferon Phase 2 Investigator Group
-
Joudi FN, Smith BJ, O'Donnell MA; National BCG-Interferon Phase 2 Investigator Group: Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer. Urol Oncol. 2006; 24: 344-8.
-
(2006)
Urol Oncol
, vol.24
, pp. 344-348
-
-
Joudi, F.N.1
Smith, B.J.2
O'Donnell, M.A.3
-
27
-
-
33845346443
-
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
-
discussion 79
-
Herr HW, Donat SM, Dalbagni G: Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol. 2007; 177: 75-9; discussion 79.
-
(2007)
J Urol
, vol.177
, pp. 75-79
-
-
Herr, H.W.1
Donat, S.M.2
Dalbagni, G.3
-
28
-
-
55649120015
-
Is maintenance Bacillus Calmette-Guérin really necessary?
-
Herr HW: Is maintenance Bacillus Calmette-Guérin really necessary? Eur Urol. 2008; 54: 971-3.
-
(2008)
Eur Urol
, vol.54
, pp. 971-973
-
-
Herr, H.W.1
-
29
-
-
20444492338
-
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials
-
discussion 91-2
-
Sylvester RJ, van der Meijden AP, Witjes JA, Kurth K: Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol. 2005; 174: 86-91; discussion 91-2.
-
(2005)
J Urol
, vol.174
, pp. 86-91
-
-
Sylvester, R.J.1
van der Meijden, A.P.2
Witjes, J.A.3
Kurth, K.4
-
30
-
-
0034105381
-
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study
-
Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, et al.: Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol. 2000; 163: 1124-9.
-
(2000)
J Urol
, vol.163
, pp. 1124-1129
-
-
Lamm, D.L.1
Blumenstein, B.A.2
Crissman, J.D.3
Montie, J.E.4
Gottesman, J.E.5
Lowe, B.A.6
-
31
-
-
0023228973
-
Toxicity of intravesical BCG and its management in patients with superficial bladder tumors
-
Orihuela E, Herr HW, Pinsky CM, Whitmore WF Jr: Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer. 1987; 60: 326-33.
-
(1987)
Cancer
, vol.60
, pp. 326-333
-
-
Orihuela, E.1
Herr, H.W.2
Pinsky, C.M.3
Whitmore W.F., Jr.4
-
32
-
-
0030111245
-
Local toxicity patterns associated with intravesical bacillus Calmette-Guérin: a Southwest Oncology Group Study
-
discussion 101
-
Berry DL, Blumenstein BA, Magyary DL, Lamm DL, Crawford ED: Local toxicity patterns associated with intravesical bacillus Calmette-Guérin: a Southwest Oncology Group Study. Int J Urol. 1996; 3: 98-100; discussion 101.
-
(1996)
Int J Urol
, vol.3
, pp. 98-100
-
-
Berry, D.L.1
Blumenstein, B.A.2
Magyary, D.L.3
Lamm, D.L.4
Crawford, E.D.5
-
33
-
-
0024329488
-
Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications
-
Lamm DL, Steg A, Boccon-Gibod L, Morales A, Hanna MG Jr, Pagano F, et al.: Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res. 1989; 310: 335-55.
-
(1989)
Prog Clin Biol Res
, vol.310
, pp. 335-355
-
-
Lamm, D.L.1
Steg, A.2
Boccon-Gibod, L.3
Morales, A.4
Hanna M.G., Jr.5
Pagano, F.6
-
34
-
-
0024331254
-
Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer
-
Steg A, Leleu C, Debré B, Boccon-Gibod L, Sicard D: Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Prog Clin Biol Res. 1989; 310: 325-34.
-
(1989)
Prog Clin Biol Res
, vol.310
, pp. 325-334
-
-
Steg, A.1
Leleu, C.2
Debré, B.3
Boccon-Gibod, L.4
Sicard, D.5
-
36
-
-
24944548274
-
Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial
-
Martínez-Piñeiro JA, Martínez-Piñeiro L, Solsona E, Rodríguez RH, Gómez JM, Martín MG, et al.: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. J Urol. 2005; 174: 1242-7.
-
(2005)
J Urol
, vol.174
, pp. 1242-1247
-
-
Martínez-Piñeiro, J.A.1
Martínez-Piñeiro, L.2
Solsona, E.3
Rodríguez, R.H.4
Gómez, J.M.5
Martín, M.G.6
-
37
-
-
0034960010
-
Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in urothelial bladder cancer
-
Nilsson S, Ragnhammar P, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol. 2001; 40: 371-90.
-
(2001)
Acta Oncol
, vol.40
, pp. 371-390
-
-
Nilsson, S.1
Ragnhammar, P.2
Glimelius, B.3
Nygren, P.4
-
38
-
-
0026780422
-
Complications of intravesical chemotherapy
-
Thrasher JB, Crawford ED: Complications of intravesical chemotherapy. Urol Clin North Am. 1992; 19: 529-39.
-
(1992)
Urol Clin North Am
, vol.19
, pp. 529-539
-
-
Thrasher, J.B.1
Crawford, E.D.2
-
39
-
-
0031883090
-
Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine
-
Gao X, Au JL, Badalament RA, Wientjes MG: Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. Clin Cancer Res. 1998; 4: 139-43.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 139-143
-
-
Gao, X.1
Au, J.L.2
Badalament, R.A.3
Wientjes, M.G.4
-
40
-
-
0035906233
-
Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial
-
Au JL, Badalament RA, Wientjes MG, Young DC, Warner JA, Venema PL, et al.: Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst. 2001; 93: 597-604.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 597-604
-
-
Au, J.L.1
Badalament, R.A.2
Wientjes, M.G.3
Young, D.C.4
Warner, J.A.5
Venema, P.L.6
-
41
-
-
0028946881
-
Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder
-
Lamm DL, Riggs DR, Traynelis CL, Nseyo UO: Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol. 1995; 153: 1444-50.
-
(1995)
J Urol
, vol.153
, pp. 1444-1450
-
-
Lamm, D.L.1
Riggs, D.R.2
Traynelis, C.L.3
Nseyo, U.O.4
-
42
-
-
0033863026
-
Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials
-
Huncharek M, Geschwind JF, Witherspoon B, McGarry R, Adcock D: Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials. J Clin Epidemiol. 2000; 53: 676-80.
-
(2000)
J Clin Epidemiol
, vol.53
, pp. 676-680
-
-
Huncharek, M.1
Geschwind, J.F.2
Witherspoon, B.3
McGarry, R.4
Adcock, D.5
-
43
-
-
0035064519
-
Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis
-
Huncharek M, McGarry R, Kupelnick B: Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res. 2001; 21: 765-9.
-
(2001)
Anticancer Res
, vol.21
, pp. 765-769
-
-
Huncharek, M.1
McGarry, R.2
Kupelnick, B.3
-
44
-
-
36448950859
-
Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results
-
Witjes JA, Hendricksen K: Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol. 2008; 53: 45-52.
-
(2008)
Eur Urol
, vol.53
, pp. 45-52
-
-
Witjes, J.A.1
Hendricksen, K.2
-
45
-
-
2442581163
-
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials
-
Sylvester RJ, Oosterlinck W, van der Meijden AP: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004; 171: 2186-90.
-
(2004)
J Urol
, vol.171
, pp. 2186-2190
-
-
Sylvester, R.J.1
Oosterlinck, W.2
van der Meijden, A.P.3
-
46
-
-
33745527134
-
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder
-
Dalbagni G, Russo P, Bochner B, Ben-Porat L, Sheinfeld J, Sogani P, et al.: Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. J Clin Oncol. 2006; 24: 2729-34.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2729-2734
-
-
Dalbagni, G.1
Russo, P.2
Bochner, B.3
Ben-Porat, L.4
Sheinfeld, J.5
Sogani, P.6
-
47
-
-
0026004545
-
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder
-
Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, et al.: A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med. 1991; 325: 1205-9.
-
(1991)
N Engl J Med
, vol.325
, pp. 1205-1209
-
-
Lamm, D.L.1
Blumenstein, B.A.2
Crawford, E.D.3
Montie, J.E.4
Scardino, P.5
Grossman, H.B.6
-
48
-
-
0037213844
-
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity
-
Böhle A, Jocham D, Bock PR: Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol. 2003; 169: 90-5.
-
(2003)
J Urol
, vol.169
, pp. 90-95
-
-
Böhle, A.1
Jocham, D.2
Bock, P.R.3
-
49
-
-
1642306191
-
Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials
-
Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD: Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int. 2004; 93: 485-90.
-
(2004)
BJU Int
, vol.93
, pp. 485-490
-
-
Shelley, M.D.1
Wilt, T.J.2
Court, J.3
Coles, B.4
Kynaston, H.5
Mason, M.D.6
-
50
-
-
1842789737
-
Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
-
discussion 686-7
-
Böhle A, Bock PR: Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology. 2004; 63: 682-6; discussion 686-7.
-
(2004)
Urology
, vol.63
, pp. 682-686
-
-
Böhle, A.1
Bock, P.R.2
-
51
-
-
36049006136
-
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update
-
Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al.: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. Urol. 2007; 178: 2314-30.
-
(2007)
Urol
, vol.178
, pp. 2314-2330
-
-
Hall, M.C.1
Chang, S.S.2
Dalbagni, G.3
Pruthi, R.S.4
Seigne, J.D.5
Skinner, E.C.6
-
52
-
-
0023387530
-
Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial
-
Hudson MA, Ratliff TL, Gillen DP, Haaff EO, Dresner SM, Catalona WJ: Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial. J Urol. 1987; 138: 295-8.
-
(1987)
J Urol
, vol.138
, pp. 295-298
-
-
Hudson, M.A.1
Ratliff, T.L.2
Gillen, D.P.3
Haaff, E.O.4
Dresner, S.M.5
Catalona, W.J.6
-
53
-
-
0023102588
-
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer
-
Badalament RA, Herr HW, Wong GY, Gnecco C, Pinsky CM, Whitmore WF Jr, et al.: A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol. 1987; 5: 441-9.
-
(1987)
J Clin Oncol
, vol.5
, pp. 441-449
-
-
Badalament, R.A.1
Herr, H.W.2
Wong, G.Y.3
Gnecco, C.4
Pinsky, C.M.5
Whitmore W.F., Jr.6
-
54
-
-
0035047153
-
Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors
-
Palou J, Laguna P, Millán-Rodríguez F, Hall RR, Salvador-Bayarri J, Vicente-Rodríguez J: Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors. J Urol. 2001; 165: 1488-91.
-
(2001)
J Urol
, vol.165
, pp. 1488-1491
-
-
Palou, J.1
Laguna, P.2
Millán-Rodríguez, F.3
Hall, R.R.4
Salvador-Bayarri, J.5
Vicente-Rodríguez, J.6
-
55
-
-
67649431728
-
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin-C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer
-
discussion 258-9
-
Malmström PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E, et al.: An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin-C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol. 2009; 56: 257-8; discussion 258-9.
-
(2009)
Eur Urol
, vol.56
, pp. 257-258
-
-
Malmström, P.U.1
Sylvester, R.J.2
Crawford, D.E.3
Friedrich, M.4
Krege, S.5
Rintala, E.6
-
56
-
-
0025335684
-
Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients
-
discussion 71-2
-
Huland H, Klöppel G, Feddersen I, Otto U, Brachmann W, Hubmann H, et al.: Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients. J Urol. 1990; 144: 68-71; discussion 71-2.
-
(1990)
J Urol
, vol.144
, pp. 68-71
-
-
Huland, H.1
Klöppel, G.2
Feddersen, I.3
Otto, U.4
Brachmann, W.5
Hubmann, H.6
-
57
-
-
0028909214
-
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group
-
Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Kruger CB, De Pauw M, et al.: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol. 1995; 153: 934-41.
-
(1995)
J Urol
, vol.153
, pp. 934-941
-
-
Bouffioux, C.1
Kurth, K.H.2
Bono, A.3
Oosterlinck, W.4
Kruger, C.B.5
De Pauw, M.6
-
58
-
-
6844252900
-
A randomized study of shortversus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group
-
discussion 289
-
Okamura K, Kinukawa T, Tsumura Y, Otani T, Itoh H, Kobayashi H, et al.: A randomized study of shortversus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group. Eur Urol. 1998; 33: 285-8; discussion 289.
-
(1998)
Eur Urol
, vol.33
, pp. 285-288
-
-
Okamura, K.1
Kinukawa, T.2
Tsumura, Y.3
Otani, T.4
Itoh, H.5
Kobayashi, H.6
-
59
-
-
0348109412
-
A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder
-
Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S: A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. J Urol. 2004; 171: 153-7.
-
(2004)
J Urol
, vol.171
, pp. 153-157
-
-
Koga, H.1
Kuroiwa, K.2
Yamaguchi, A.3
Osada, Y.4
Tsuneyoshi, M.5
Naito, S.6
-
60
-
-
18144424943
-
Long term prophylaxis with mitomycin C (MMC) further reduces tumor recurrence compared to short term prophylaxis with MMC or bacillus Calmette-Guerin (BCG)
-
[Abstract]
-
Conrad S, Friedrich MG, Schwaibold H, Pichlmeier U, Schildt K, Wolf N: Long term prophylaxis with mitomycin C (MMC) further reduces tumor recurrence compared to short term prophylaxis with MMC or bacillus Calmette-Guerin (BCG). J Urol. 2004; 171: [Abstract] 271.
-
(2004)
J Urol
, vol.171
, pp. 271
-
-
Conrad, S.1
Friedrich, M.G.2
Schwaibold, H.3
Pichlmeier, U.4
Schildt, K.5
Wolf, N.6
-
61
-
-
34548324433
-
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma
-
Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. Eur Urol. 2007; 52: 1123-29.
-
(2007)
Eur Urol
, vol.52
, pp. 1123-1129
-
-
Friedrich, M.G.1
Pichlmeier, U.2
Schwaibold, H.3
Conrad, S.4
Huland, H.5
-
62
-
-
0030914050
-
The treated natural history of high risk superficial bladder cancer: 15-year outcome
-
Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol. 1997; 158: 62-7.
-
(1997)
J Urol
, vol.158
, pp. 62-67
-
-
Cookson, M.S.1
Herr, H.W.2
Zhang, Z.F.3
Soloway, S.4
Sogani, P.C.5
Fair, W.R.6
-
63
-
-
0141460505
-
Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial
-
EORTC Genito-Urinary Tract Cancer Group
-
van der Meijden AP, Sylvester RJ, Oosterlinck W, Hoeltl W, Bono AV; EORTC Genito-Urinary Tract Cancer Group: Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol. 2003; 44: 429-34.
-
(2003)
Eur Urol
, vol.44
, pp. 429-434
-
-
van der Meijden, A.P.1
Sylvester, R.J.2
Oosterlinck, W.3
Hoeltl, W.4
Bono, A.V.5
-
64
-
-
0037404879
-
Defining bacillus Calmette-Guerin refractory superficial bladder tumors
-
Herr HW, Dalbagni G: Defining bacillus Calmette-Guerin refractory superficial bladder tumors. J Urol. 2003; 169: 1706-8.
-
(2003)
J Urol
, vol.169
, pp. 1706-1708
-
-
Herr, H.W.1
Dalbagni, G.2
-
65
-
-
0037422679
-
Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect
-
Luo Y, Chen X, O'Donnell MA: Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect. Cytokine. 2003; 21: 17-26.
-
(2003)
Cytokine
, vol.21
, pp. 17-26
-
-
Luo, Y.1
Chen, X.2
O'Donnell, M.A.3
-
66
-
-
72449169235
-
The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer()
-
[Epub ahead of print]
-
Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LC, et al.: The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer(). Urol Oncol. 2009; 7. [Epub ahead of print]
-
(2009)
Urol Oncol
, pp. 7
-
-
Andrade, P.M.1
Chade, D.C.2
Borra, R.C.3
Nascimento, I.P.4
Villanova, F.E.5
Leite, L.C.6
-
67
-
-
62149100674
-
Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model
-
Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LC, Andrade E, et al.: Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model. J Exp Clin Cancer Res. 2008; 27: 78.
-
(2008)
J Exp Clin Cancer Res
, vol.27
, pp. 78
-
-
Chade, D.C.1
Borra, R.C.2
Nascimento, I.P.3
Villanova, F.E.4
Leite, L.C.5
Andrade, E.6
-
68
-
-
68549123471
-
Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro
-
[Epub ahead of print]
-
Liu W, O'Donnell MA, Chen X, Han R, Luo Y: Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro. Cancer Immunol Immunother. 2009; 13. [Epub ahead of print]
-
(2009)
Cancer Immunol Immunother
, pp. 13
-
-
Liu, W.1
O'Donnell, M.A.2
Chen, X.3
Han, R.4
Luo, Y.5
-
69
-
-
59349116084
-
Intravesical mycobacterial cell wall-DNA complex in the treatment of carcinoma in situ of the bladder after standard intravesical therapy has failed
-
Morales A, Phadke K, Steinhoff G: Intravesical mycobacterial cell wall-DNA complex in the treatment of carcinoma in situ of the bladder after standard intravesical therapy has failed. J Urol. 2009; 181: 1040-5.
-
(2009)
J Urol
, vol.181
, pp. 1040-1045
-
-
Morales, A.1
Phadke, K.2
Steinhoff, G.3
-
70
-
-
45849140589
-
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
-
Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al.: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2008; 54: 303-14.
-
(2008)
Eur Urol
, vol.54
, pp. 303-314
-
-
Babjuk, M.1
Oosterlinck, W.2
Sylvester, R.3
Kaasinen, E.4
Böhle, A.5
Palou-Redorta, J.6
|